Thrombosis
Commentary
On Second Thought: Aspirin for Primary Prevention — What We Really Know
Recommendations vis-à-vis aspirin have evolved at a dizzying pace.
From the Journals
Current Hydroxychloroquine Use in Lupus May Provide Protection Against Cardiovascular Events
Hydroxychloroquine demonstrated protective effects against cardiovascular events in patients with systemic lupus erythematosus.
Latest News
Just A Single Night of Poor Sleep May Change Serum Proteins
One night of sleep deprivation can have an impact on proteins in blood serum, though clinical implications are not yet clear.
Latest News
New Study Links Sweetener to Heart Risk: What to Know
Study suggests consuming erythritol, a sweetener widely found in sugar-free and keto food products, could spur a prothrombotic response.
Latest News
Why Are We Undertreating So Many Pulmonary Embolisms?
Based on deidentified data, less than half of one percent of patients who experience a PE receive advanced therapy.
Latest News
Gene Tests Could Predict if a Drug Will Work for a Patient
Pharmacogenetics could help physicians determine which patients would and would not benefit from medications.
Latest News
Roche Blood Test for Lp(a) Designated Breakthrough Device
Device intended to identify adults with elevated Lp(a) levels, and who may benefit from therapy, is granted breakthrough status.
Latest News
Anticoagulants Safe With Enzyme-Inducing Meds for Epilepsy
“A potential explanation may be pharmacokinetic interaction with enzyme-inducing antiseizure medications occurring to a degree that lowers DOAC...
Conference Coverage
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
Conference Coverage
Longer edoxaban may benefit cancer patients with distal DVT
“This is the first and only randomized trial to show the superiority of longer duration over shorter duration of anticoagulation therapy for...